Estimated Societal Value of Lecanemab in Patients with Early Alzheimer ’s Disease Using Simulation Modeling

ConclusionThe economic study suggested that lecanemab plus SoC would improve health and humanistic (quality of life) outcomes and reduce economic burden for patients and caregivers in early AD.

Source: Neurology and Therapy - March 16, 2023 Category: Neurology Source Type: research